„Passionate about gut health – we unveil the power of the microbiome by developing & promoting break-through evidence-based probiotics that significantly improve patients‘ quality of life.“
– SYNformulas mission statement

A Global Leader in Probiotics

SYNformulas GmbH

A Global Leader in Probiotics

2012 by Dr. Clemens Fischer

Business model:
SYNformulas researches the complex relationship between health and the human microbiome. Based on the scientific findings, SYNformulas develops evidence-based probiotic therapies which significantly improve the quality of life.

Managing directors:
David Rietbrock, Chief Marketing Officer

Company headquarters:
Gräfelfing, Munich region

Food supplements, medical products and products for special medical purposes under the brand name Kijimea®.


Company portrait

SYNformulas is a globally leading probiotics company focused on researching the human microbiome and developing breakthrough, evidence based probiotics that significantly improve the quality of life. Under the brand Kijimea® the company's medical products, nutritional supplements and products for supplementary balanced diets are sold in ten countries on a pharmacy exclusive basis.

SYNformulas achieved a breakthrough in the treatment of Irritable Bowel Syndrome: In two independent studies the patented bacterial strain B. bifidum MIMBb75, which is used for the products Kijimea® IBS and Kijimea® IBS PRO, showed significant efficacy in the widespread disease Irritable Bowel Syndrome and was most recently included in the S3 guideline Irritable Bowel Syndrome. For its pioneering product development with clinically proven efficacy, the company relies on an expert research & development team as well as cooperation with a broad network of internationally recognised researchers and universities.

SYNformulas is based in Gräfelfing close to Munich and is a subsidiary of the healthcare group FUTRUE, which operates internationally with over 20 companies.

Company Management

David Rietbrock

David Rietbrock
CEO SYNformulas GmbH

David Rietbrock is Managing Director and Chief Marketing Officer of SYNformulas GmbH. He is responsible for the company's marketing and creative activities, sets significant growth impulses in the areas of internationalisation and business development and manages the sales force. In addition, David Rietbrock is responsible for expanding the SYNformulas research and development pipeline.

Prior to joining SYNformulas, he was an Associate Partner at McKinsey & Company, advising clients from various industries with a focus on marketing and sales. Previously he worked for various industrial and automotive companies. David Rietbrock has got a Master's degree in Industrial Engineering from the University of Erlangen Nuremberg. He is married and has got two sons.

SYNformulas media contact

For questions and further information please contact